Treatment of A549 cancer cells with YC-1 (10–100 μM) prior to hypoxia exposure significantly prolonged plasma clotting time to near that observed in the normoxic control group, indicating that hypoxia-induced TF activity was inhibited by YC-1 (Figure 2B). Here, TF is linked to cancer.